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PregnancyObjective: To evaluate the L-arginine/NO system and its role in insulin signaling and endo-
thelial function during the pregnancy of women of different BMI categories.
Study design: Twelve women with BMIP 25 were compared with 10 normal-weight
women in a fasting condition after the infusion of L-arginine (20 g in 3 h) and after the
evaluation of the ﬂow-mediated vasodilation (FMD) of the brachial artery between the
9th–12th and 24th–27th weeks. Blood samples for insulin and nitrite/nitrate (NOx) were
collected at baseline and after 1, 2 and 3 h after initiating the infusion.
Results: In both trimesters, the baseline NOx levels were similar among groups. In the 1st
trimester of the lean women, there was a NOx increase in response to L-Arg (AUC: 1328; 3,
3173), which had increased by the 2nd trimester (AUC: 3884; 1905, 7686); in overweight/
obese women, no responses to L-Arg were found in the 1st or 2nd trimesters. In the 1st tri-
mester, the insulin levels were signiﬁcantly reduced in both groups after L-Arg infusion.
Although the insulin levels in all BMI categories were higher in the 2nd trimester, such lev-
els during weeks 24–27 were suppressed only in normal-weight women after L-Arg infu-
sion. The FMD was higher during both trimesters in the lean controls and was impaired
in the overweight/obese subjects.
Conclusions: NO availability is impaired in overweight/obese women during pregnancy,
which affects endothelial functioning and interferes with insulin regulation. These mecha-
nisms could be involved in the development of hypertensive disorders and glucose intoler-
ance in this population.
 2014 International Society for the Study of Hypertension in Pregnancy Published by
Elsevier B.V. All rights reserved.Introduction compared with pre-pregnancy levels [3]. IR is a commonPregnancy is physiologically characterized by hyperin-
sulinemia and insulin resistance (IR) [1,2]. During the third
trimester, insulin sensitivity is reduced by up to 50–70%condition in overweight/obese subjects because of the
endocrine activity of adipokines produced by visceral adi-
pose tissue. The increased visceral adipose tissue is known
to regulate glucose homeostasis, energy metabolism, the
immune system, coagulation and blood pressure [4]. In par-
ticular, tumor necrosis factor-a (TNF-a) and non-esteriﬁed
fatty acids (NEFA) appear to have a leading role in insulin
resistance development, and concentrations of TNF-a and
NEFA are both increased in the obese population [4–6].
In addition to glucose metabolism, insulin is implicated
in the regulation of endothelial function and acts through
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dylinositol (PI) 3-kinase-dependent pathway and the mito-
gen-activated protein (MAP) kinase pathway. The activation
of PI 3-kinase is a necessary condition for the insulin-stim-
ulated production of nitric oxide (NO) by the endothelium
and for GLUT4 translocation, which allows glucose uptake
in the skeletal muscle [7]. This pathway is involved in phys-
iological intracellular insulin signaling transmission. There-
fore, insulin signaling in the vascular endothelium results in
increased blood ﬂow and contributes to glucose disposal,
suggesting a possible mechanism that couples glucose
metabolism with hemodynamic mechanisms [7,8]. More-
over, the increased blood ﬂow itself leads to a greater inﬂow
of insulin to the skeletal muscle, which further increases
glucose uptake.Moreover, inhibitingNO production precip-
itates a parallel decline in blood ﬂow and a decrease in
glucose utilization of approximately 40% [9].
During IR, insulin induces extracellular signal-regulated
kinase (ERk1/ERk2) and, as a consequence, mitogen-acti-
vated protein kinase, which leads to endothelin-1 produc-
tion and atherosclerosis onset. However, the transmission
of intracellular signaling is impaired.
In the endothelium, NO is produced by endothelial NO
synthase enzyme (eNOS) from the amino acid L-arginine,
in response to either shear stress or hormonal stimuli
(i.e., insulin), inducing endothelial-dependent vasodilation
[10].
Hyperinsulinemia, related to IR and resultant from
increased glucose levels, enhances the production of reac-
tive oxygen species (ROS) and, thus, oxidative stress and
endothelial dysfunction [10–13]. Adipokines (particularly
TNF-a) could activate several kinases, which reduce PI
3-kinase function, thereby decreasing glucose uptake and
eNOS function [7].
According to previously exposed mechanisms, obesity
negatively affects endothelial function. It has been demon-
strated that endothelial-dependent vasodilation is reduced
by 40–50% in obese subjects (with or without diabetes)
compared with normal-weight subjects [14]. In the same
study, increased body mass index (BMI) categories corre-
spond to a progressive decrease of endothelial-dependent
vasodilation [14].
A previous study performed by our group demonstrated
that an acute L-arginine (L-Arg) infusion was able to reveal
a NOS impairment in pre-eclamptic (PE) women, as dem-
onstrated by signiﬁcantly lower serum L-citrulline produc-
tion with respect to normotensive controls [15]. The serum
NO levels were increased in the controls but not in the PE
women, which supports the hypothesis that preeclampsia
is characterized by a dysfunction of the L-Arg/NO pathway
[15]. Moreover, we have also demonstrated that an acute
L-Arg infusion was able to induce a vasodilation in pla-
centa-related fetal growth restriction, improving uterine
artery blood ﬂow velocimetry [16].
The L-Arg/NO pathway is also involved in glucose
metabolism. Recent studies demonstrate that an alteration
in NO availability appears to be involved in the pathogen-
esis of type 2 diabetes mellitus (T2 DM) [7,17].
Considering that the prevalence of obesity is increasing
in the general population and that the top BMI categories
in pregnant women are also increasing, we aim to evaluatethe L-Arg/NO regulatory system in lean and obese pregnant
women for both insulin signaling and endothelial function.Methods
Subjects
The study was approved by the local ethics committee.
After signing an informed consent form, 22 healthy preg-
nant women volunteered for the study.
The inclusion criteria were Caucasian ethnicity, age 18–
40 years, single pregnancy, and gestational age between 9
and 12 weeks at the time of recruitment.
Exclusion criteria were concomitant disorders (chronic
hypertension or pre-gestational type 1 or 2 diabetes melli-
tus) or previously complicated pregnancies.
Blood pressure, height and weight were measured, and
BMI was calculated. Morbidly obese subjects were
excluded. The 12 overweight/obese women (BMIP 25
kg/m2) were compared with 10 normal-weight women
(BMI range 18–25 kg/m2).
All volunteers were enrolled at the Obstetric Unit of Pol-
iclinico Hospital, University of Modena and Reggio-Emilia.
Study design
The enrolled subjects underwent both L-Arg infusion
and evaluation of the endothelial-dependent ﬂow-medi-
ated vasodilation (FMD) of the brachial artery twice during
pregnancy. The tests were performed between the 9th and
12th, as well as between the 24th and 27th weeks, respec-
tively, within 2 days of each other.
In the 1st trimester and within the 12th week, the fast-
ing glucose and insulin levels were measured to evaluate
the homeostasis model assessment (HOMA) index. The
HOMA index was calculated as follows: [(fasting glucose
mg/dl)  (fasting insulin mUI/L)]/405. A HOMA index
higher than 2.5 is suggestive of IR.
In a fasting condition between 8 and 9 A.M., the L-Arg
(20 g in 500 ml physiological solution) was continuously
infused for 3 h. Blood samples for insulin and nitrite/
nitrate (NOx) were collected at baseline and after 1, 2
and 3 h after initiating the infusion.
Methods
The serum NOx concentration was obtained after a
reduction of nitrates to nitrites with cadmium. The nitrite
assay was performed using the colorimetric method based
on a Griess reaction, and the results are expressed in lM/L.
The quantitative determination of the plasma insulin levels
was obtained using the ELISA method, and the concentra-
tions are expressed in lIU/ml.
The ultrasound assessment of FMD was performed to
measure the percent change of the brachial artery diame-
ter in response to increased blood ﬂow shear stress, as pre-
viously described by Coretti et al. [18]. The measurements
were performed in a dark, quiet –>and temperature-con-
trolled room –>in the morning after at least 12 h of fasting.
The subjects did not exercise and did not ingest substances
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for at least 12 h prior to the measurements. The subjects
were asked to rest for at least 10 min (min) prior to the
FMD measurements. The brachial artery diameter was im-
aged using a 7.5 MHz linear transducer ultrasound system
(LOGIQ 3, GE Medical Systems, Milwaukee, WI, USA). After
the baseline measurements were recorded, a blood pres-
sure cuff was inﬂated until reaching occlusive pressure
on the most proximal portion of the forearm for 5 min to
induce reactive hyperemia. Both the measurements in
millimeters and as percent changes of brachial artery
diameter were calculated at 1 and 5 min after the cuff
release. To calculate the ﬂow-mediated dilation, the per-
cent diameter changes were determined as follows: (diam-
eter after reactive hyperemia-baseline diameter)/baseline
diameter  100.
Statistical analysis
Data were recorded to a database and analyzed using
SPSS Statistics version 19. According to the distribution,
the Mann–Whitney U-test was used. The Wilcoxon test
was applied within the experimental group. To compare
the insulin and NOx responses to infusion, the area under
the curve (AUC) was calculated using the trapezoidal rule
and by subtracting the baseline values.
The values are expressed as the means ± standard devi-
ation, the median and interquartile range or the number
with the percentage sign (%) in brackets as appropriate.
A p value of less than 0.05 was the threshold for statis-
tical signiﬁcance.Results
The clinical features of the women included in the study
are described in Table 1. At enrollment, both the maternal
age (25.6 ± 4.5 vs. 32.1 ± 5.4 years) and BMI (21.7 ± 2.2 vs.
32.2 ± 6.2 kg/m2) were signiﬁcantly higher in the over-
weight/obese than the normal-weight women (p < 0.001).
According to the HOMA index, 7 overweight/obese preg-
nant patients and just 1 normal-weight woman were
found to be resistant to insulin, although this differenceTable 1
Clinical features of women stratiﬁed for BMI categories.
Normal-
weight
Overweight/
obese
p Value
Serum glucose levels 78.4 ± 5.3a 82.8 ± 9.3 NS
(70–84) (71–101)
Serum insulin levels 8.0 ± 5.1 17.6 ± 16.5 p = 0.008
(2.8–19.1) (6.5–74.0)
HOMA index 1.7 ± 1.0 3.8 ± 4.2 NS
(0.5–4.0) (1.3–18.4)
HOMA > 2.5 1 (10.0%)b 7 (58.3%) NS
Systolic blood pressure
(mmHg)
104.1 ± 10.4 121.6 ± 15.1 0.004
(85.0–
115.0)
(95.0–137.0)
Diastolic blood pressure
(mmHg)
61.8 ± 6.0 73.3 ± 9.6 0.002
(53.0–68.0) (55.0–85.0)
a Mean ± SD with range in brackets.
b N with % in brackets.was not statistically signiﬁcant. At both trimesters, any
symptom (i.e., vomiting, cephalgia, etc.) during or after
the L-Arg infusion was observed in our study population.
In the 1st (normal-weight: 22.2 ± 13.9 lM/L, over-
weight/obese: 33.1 ± 14.9 lM/L) and 2nd trimester (nor-
mal-weight: 20.0 ± 11.6 lM/L, overweight/obese: 29.3 ±
15.8 lM/L) evaluations, the baseline NOx levels were simi-
lar among the 2 groups. In the normal-weightwomen in the
1st trimester, there was a NOx increase in response to the
L-Arg infusion (AUC: 1328; 3, 3173), which had further in-
creased by the 2nd trimester (AUC: 3884; 1905, 7686). In
the overweight/obese women, no responses to L-Arg
occurred in the 1st or 2nd trimester (Fig. 1).
During the 1st trimester, the fasting insulin levels were
signiﬁcantly higher in the overweight/obese group
(17.6 ± 12.5 lIU/ml) than in the control group
(8.0 ± 5.1 lIU/ml; p < 0.01); however, in the 2nd trimester,
the fasting insulin levels became similar (overweight/ob-
ese: 17.3 ± 8.2 lIU/ml; normal-weight: 18.0 ± 11.4 lIU/
ml). In the 1st trimester, the insulin levels were signiﬁ-
cantly reduced after 3 h of L-Arg infusion in both groups
(p = 0.05) (Fig. 2). However, in the 2nd trimester, the insu-
lin levels were signiﬁcantly lower only in the normal-
weight group (AUC: 229; 515, 73) and not in the
overweight/obese women (AUC:86;594, 165; p = 0.02).
The brachial artery dilation response to increased blood
ﬂow shear stress (both expressed in millimeters and as
percent changes of the brachial artery diameter after the
cuff release) in lean women was higher in the 1st than
the 2nd trimester (Table 2). In the overweight/obese wo-
men, no vasodilatory responses were observed in the 1st
or 2nd trimester.
Discussion
Human pregnancy is associated with dramatic changes
in the maternal cardiovascular system, leading to a decrease
in blood pressure as a consequence of reduced peripheral
vascular resistances [19]. NO plays a pivotal role in this con-
text [20–23]. The data of our study support such an obser-
vation and demonstrate an impairment of NO availability,
namely in the 2nd trimester, in overweight/obese women.
Consequently, both endothelial-dependent vasodilation
and insulin regulation appear to be compromised.
Endothelial dysfunction during pregnancy is involved in
the pathophysiology of several adverse conditions such as
preeclampsia [24–26], which is precipitated by the inabil-
ity to release NO [27] and leads to a worsening of FMD
[28,29]. However, PE and gestational hypertension have
an increased prevalence in obese women and result in
more preterm deliveries and signiﬁcant neonatal morbid-
ity and mortality [30]. Our ﬁndings suggest that such preg-
nancy complications could be related to impaired NO
release. Whether such impairment is a consequence of pre-
eclampsia or, alternatively, whether it plays a causal role in
the onset of this condition remains to be demonstrated.
Previous studies have demonstrated that NO is pro-
duced in the endothelium of placental vessels by eNOS
[31]. Because there is no innervation of such vessels, vaso-
dilation has been thought to occur primarily through
locally produced vasodilators [32–34]. Thus, the most
Fig. 1. NOx production in response to L-Arg infusion. AUC: area under the curve.
Fig. 2. Insulin levels in response to L-Arg infusion.
Table 2
Brachial artery diameter changes in response to increased blood ﬂow shear stress after cuff release.
1st Trimester 2nd Trimester
Normal-weight Overweight/obese Normal-weight Overweight/obese
Baseline 3.6 ± 0.7a 3.7 ± 0.7 4.0 ± 0.2 3.7 ± 0.8
1st Minute 4.4 ± 0.9 4.4 ± 0.9 5.1 ± 0.7 4.0 ± 0.9
(% Change) (23.4 ± 12.1)b (16.9 ± 12.3) (26.5 ± 10.9) (7.92 ± 9.6)
5th Minute 6.0 ± 1.3 4.6 ± 0.7 5.4 ± 0.5 4.3 ± 1.0
(% Change) (67.4 ± 32.9) (24.7 ± 16.9)* (32.18 ± 6.7) (16.7 ± 13.3)*
a Means ± SD diameter changes in millimeters (mm).
b Means ± SD % change over baseline.
 p < 0.05 in respect to normal weight.
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only constitutively produced but is also dramatically stim-
ulated by increases in shear stress (which occurs with
increased blood ﬂow) [20–23]. However, another factor
that should be taken into account is the status of chronic
oxidative stress, which has been demonstrated in obese
women through the exposure of endothelium to adipokine
activity [10–13]. Inﬂammatory cytokines, particularly TNF-
a, decrease the expression of mitochondrial oxidativephosphorylation genes, which increases oxidative cellular
stress and the accumulation of reactive oxygen species
(ROS) [35]. Therefore, we cannot exclude that the low
detection of NOx in obese/overweight women during the
course of pregnancy is a consequence of a reduced produc-
tion or faster inactivation.
Moreover, capillary recruitment and blood ﬂow en-
hance the delivery of glucose in skeletal muscle, in which
mass action promotes glucose transport. Elevations in
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muscle, where insulin directly promotes glucose uptake
through stimulating the translocation of GLUT4 [7].
Our data are in agreement with previous ﬁndings and
demonstrate that women with a BMIP 25 kg/m2 pre-
sented higher insulin levels than normal-weight women
as early as the 1st trimester [4–6]. Moreover, as expected,
lean women increase their baseline insulin in the 2nd tri-
mester to compensate for the physiological rise of insulin
resistance; these women implement the positive glucose
gradient from the maternal to fetal side for proper fetal
growth [1,2].
After the L-Arg infusion at weeks 24–27, the insulin
levels appeared to be reduced only in the normal-weight
women. This ﬁnding could be explained by the lack of
NO availability in overweight/obese subjects, highlighting
the role of NO in intermediate metabolism.
However, NO is also involved in insulin regulation, as
previously demonstrated [36]. An alteration in NO avail-
ability appears to be implicated in the pathogenesis of type
2 diabetes mellitus [7,17,37]. In islet b-cells, pro-inﬂamma-
tory cytokines (largely expressed by visceral adipose tis-
sue) acutely activate the expression of the Nos2 gene
(that encodes inducible nitric oxide synthase (iNOS)),
which ultimately impairs insulin release [36]. This phe-
nomenon could explain our ﬁndings: in the 2nd trimester,
the insulin levels appear to be reduced only in the normal-
weight women.
In summary, these data demonstrate that NO availabil-
ity is impaired in overweight/obese women compared with
lean controls during the course of pregnancy. The reduced
NO availability affects endothelial-dependent vasodilation
and interferes with insulin regulation. These mechanisms
could be involved in the increased risk of developing
hypertensive disorders and glucose intolerance in the
overweight/obese population.Author contributions
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